One-Year Postoperative Mortality in MEN1 Patients Operated on Gastric and Duodenopancreatic Neuroendocrine Tumors: An AFCE and GTE Cohort Study.

Date publication

août 2019

Journal

World journal of surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CADIOT Guillaume , Dr GOUDET Pierre

Tous les auteurs :
Christou N, Mathonnet M, Gaujoux S, Cadiot G, Deguelte S, Kraimps JL, Lifante JC, Menegaux F, Mirallié E, Muscari F, Carnaille B, Pattou F, Sauvanet A, Goudet P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31384998

Résumé

In MEN1 patients with gastric and duodenopancreatic neuroendocrine tumors (GPD-NET), surgery aims to control secretions or to prevent metastatic spread, but after GPD-NET resection, postoperative mortality may be related to the surgery itself or to other associated MEN1 lesions with their own uncontrolled secretions or metastatic behavior.

Référence

World J Surg. 2019 Aug 5;: